Amantadine specifically inhibits the release of virus particles from cells infected with the Rostock (H7N1) strain of influenza A virus, apparently as a consequence of a membrane protein M2-mediated conversion of haemagglutinin (HA) to its low pH conformation. Electron microscopic observations, together with immunogold labelling, showed that amantadine action does not alter the distribution of HA on the cell surface nor does it prevent the formation of budding virus particles. It was not possible, however, to discern whether low pH HA inhibited the final stage in virus maturation, i.e. pinching off, or simply prevented release of fully formed particles.
Amantadine (1-amino adamantane hydrochloride) and rimantadine (~-methyl-l-adamantanemethylamine hydrochloride) are effective in the prophylaxis and treatment of influenza A infections (Wingfield et al., 1969; Van Voris et al., 1981 ; Dolin et al., 1982; Hall et al., 1987; Tominack & Hayden, 1987) . Their actions are highly selective both in vivo and in vitro. In cell culture, micromolar concentrations of these drugs specifically inhibit the replication of influenza A viruses but are inactive against influenza B infections. Characterization of drug-resistant mutants has identified the primary target of the action as the transmembrane domain of the M2 membrane protein (Hay et al., 1985; Belshe et al., 1988; Bean et al., 1989; Hayden et al., 1989) . With many influenza virus strains inhibition occurs at an early stage in virus infection, preventing virus uncoating (Kato & Eggers, 1969; Bukrinskaya et al., 1982) . For certain influenza H7 virus infections on the other hand, inhibition occurs principally at a later stage during replication and prevents virus maturation without affecting significantly the synthesis of most virus components (Hay et al., 1986) . Analyses of genetic reassortants between amantadine-resistant and -sensitive viruses indicated the importance of haemagglutinin (HA) in influencing susceptibility to this latter action (Scholtissek and Faulkner, 1979; Hay et al., 1986) . Furthermore, it appears that the block to virus release is the direct consequence of an amantadine-induced, M2 protein-mediated alteration of HA to its low pH conformation (Skehel et al., 1982) during its transport to the surface of drug-treated infected cells (Sugrue et al., Parallel experiments confirmed that amantadine (5 ~tM) added to MDCK cells 1 h after infection with the Rostock strain of influenza A virus (A/chicken/Germany/34, H7N1) at a multiplicity of approximately 50 reduced the yield of virus 6 h after infection by greater than 90%, as assayed by either HA production or isolation of 35S-labelled virus, (Hay et al., 1986) . In contrast, drug treatment caused no detectable decrease in the yield of virus from cells infected with an amantadine-resistant variant, Rostock R. Attempts to obtain sufficient virus from amantadine-treated cells for morphological examination by electron microscopy were unsuccessful. Electron microscopic observation of negatively stained specimens of culture medium or virus pellets (200000g, 60 min) also failed to show that virus particles were produced by amantadine-treated infected cells; this was in contrast to virus production by control infected cells.
For electron microscopy of thin sections, MDCK cell monolayers were fixed overnight in 1% paraformaldehyde, 1,25~ glutaraldehyde in 0.1 M-sodium cacodylate pH 7.2. Cells were pelleted, post-fixed for 1 h in 1% osmium tetroxide, block-stained with 1 ~o uranyl acetate, dehydrated and embedded in Araldite. Sections (70 nm) were stained with ethanolic uranyl acetate and Reynold's lead citrate and viewed with a Jeol JEM 1200EX electron microscope. Examination of thin sections of Rostock virus-infected MDCK cells (Fig. l a and b) clearly showed that virus bud formation was not impaired by amantadine treatment and neither was the polarized distribution of budding virus on the apical surface. Estimates of the number of virus particles per unit length of sectioned cell surface indicated that they were three-to four-fold greater on the surface of amantadine-treated cells at 6 h post-infection as compared to the control (Fig.  I e and f) . Similar results were obtained whether cells were infected for 4 or 7 h. Furthermore, similar effects of amantadine were also noted with infected chick embryo fibroblasts, although the general distribution of budding particles on these cells made quantification difficult.
Differences in the morphology of HA were evident at higher magnification ( Fig. 1 c and d) . In contrast to the regular array of HA spikes on particles budding from control infected cells (Fig. l c) , the spike layer on particles budding from amantadine-treated cells is irregular and diffuse (Fig. 1 d) , similar in appearance to low pH HA on virus particles exposed briefly to pH 5 (Ruigrok et al., 1984 (Ruigrok et al., , 1986 .
Whether the block to virus production occurs at the final stage in virus maturation, which involves pinchingoff, or whether amantadine simply prevents release of fully formed virus particles was not resolved. The proportion (5 to 10~) of virus particles clearly attached to the cell surface via a thin membrane stalk was not discernibly different in drug-treated and control cells. When 200 nm thick sections were tilted in the microscope, more stalks were observed but for about 80 ~ of the virions the nature of their attachment was not evident. In the thick sections virus particles were always observed in association with microvilli. Apparently, in the thin (70 nm) sections, these microvilli are often outside the plane of sectioning and virus therefore appears to be aggregated (Fig. I b) . This was clearly different from the extensive aggregation observed in the absence of an active neuraminidase (Palese et al., 1974; Palese & Compans, 1976) and treatment with neuraminidase did not promote virus release. Moreover, there is no genetic evidence to implicate the virus neuraminidase in amantadine action (Lubeck et al., 1978; Hay et al., 1979 Hay et al., , 1985 Scholtissek & Faulkner, 1979; Belshe et al., 1988; Bean et al., 1989) . Various other treatments of drugtreated infected cells also failed to promote the release of virus particles. These included incubation for 15 min with medium at alkaline pH (up to pH 8.9), NaC1 concentrations of up to 0.3 M and digestion with trypsin, bromelain or thermolysin. Treatment with 20 mM-DTT, known to remove most HA1 from low pH HA on amantadine-treated cells (Sugrue et al., 1990) , also had no effect, indicating that interaction via this component is not responsible for attachment.
The distribution of HA on the surface of infected cells was investigated by immunogold labelling. Five hours after infection cells were fixed with 3~ paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at room temperature, washed and incubated for 1 h at room temperature with a 10-fold dilution of monoclonal antibody (MAb) in PBS with 0-5~ bovine serum albumin (BSA). Cells were then washed and incubated for 1 h at room temperature with a 10-fold dilution of Auroprobe (EM Protein A G10; Janssen) in PBS with 0.5~ BSA. Thin sections were prepared as described above. Three MAbs were used: HC2 which recognizes site A (Wiley et al., 1981) and reacts equally well with uncleaved and cleaved forms of native and low pH HA; (653) * Average number of gold particles per budding virion. Within parentheses, total number of virus particles counted. Counts were from electron microscopy negatives, including only viruses that were sectioned through the middle.
i" Plus 5 ~tM-amantadine added 1 h post-infection.
HC58, which recognizes the interface between the HA subunits (site D) and reacts only with native HA; and H9, prepared against pH 5-treated HA, which recognizes only the low pH form (Sugrue et al., 1990 ). An ELISA (Table 1 ) done in parallel as described by Sugrue et al. (1990) showed that MAbs HC58 and H9 readily distinguished HA on control and amantadine-treated cells, respectively, whereas the data for MAb HC2 indicate that drug treatment caused no significant difference in the amount of HA produced. Electron micrographs of immunogold-labelled infected cells are shown in Fig. 2 and the numbers of gold particles per virion are given in Table 1 . There was little difference in MAb HC2 labelling of control and drug-treated ceils, whereas MAbs HC58 and H9 labelled predominantly control and amantadine-treated infected cells, respectively. In all cases more than 90~ of the label was associated with virus or buds and there appeared to be no difference in the distribution of HA on the viral and cell surfaces between control and drug-treated ceils.
In conclusion, therefore, it is apparent that the efficiency and morphology of virus bud formation is not impaired by amantadine action, which results in an accumulation of budding virus particles. The precise nature and location of the block was, however, not ascertained. It was not possible to discern whether the pinching off of virus particles was inhibited or whether fully formed particles simply remained attached to ceils. In this context, it should be noted that, in contrast to many influenza A viruses, Rostock virus particles show a particular tendency to aggregate following exposure to pH 5 and this aggregation is not reversed by treatment with high pH or trypsin (Ruigrok et al., 1984) . To date, studies using different virus-cell systems and various conditions which reverse amantadine action (Sugrue et al., 1990; A. Hay, unpublished data) have shown a strict correlation between the alteration of HA and inhibition of virus production. Furthermore, addition of amantadine later than 20 rain after the start of HA synthesis causes neither the conformational change in HA nor prevents its incorporation into virus particles (Hay et al., 1986; Sugrue et al., 1990 ). It appears most likely, therefore, that the block to virus release is a consequence of the particular properties of low pH HA rather than the result of inhibition of some other function of M2 involved directly in virion assembly (Zebedee & Lamb, 1989 
